Literature DB >> 18084807

A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis.

Vikas Agarwal1, Ram Singh, Sandeep Chauhan, Anita Tahlan, Chirag Kamal Ahuja, Deepak Goel, Lily Pal.   

Abstract

Neuropathy in rheumatoid arthritis (RA) may result secondary to entrapment, vasculitis, and drug toxicity. We aimed to study clinical and electrophysiological neuropathy and pathological changes in sural nerve in patients with RA. One hundred eight patients of RA, fulfilling American College of Rheumatology 1987 criteria (mean age, 45.83 years; M/F 1:3, 80.3% seropositive) were examined clinically and electrophysiologically for evidence of peripheral neuropathy. Sural nerve biopsies were performed in the involved cases. In all RA patient medications, disease activity, results of blood tests, and X-rays of affected joints were recorded. Twenty-three patients complained of paresthesias in the extremities. Vibration sensations were decreased in 9, and tendon reflexes were decreased or absent in 28 patients. Sixty-two (57.4%) patients had electrophysiologic evidence of neuropathy. Of these 53 (85.5%) patients had pure sensory or sensory motor axonal neuropathy (mononeuritis multiplex, n = 7), while 9 (14.5%) had demyelinating neuropathy (chronic inflammatory demyelinating polyneuropathy, n = 1). Carpal tunnel syndrome was seen in 11 (10.1%) patients (associated with neuropathy in 6). Of 23 sural nerve biopsies available, perineurial thickening (n = 5, amyloid deposits n = 4), perivascular lymphomononuclear cell infiltrate (n = 4), loss of myelin fibers (n = 2), and necrotizing vasculitis (n = 1) were found. Clinically, however, seven patients had evidence of cutaneous vasculitis. Comparing the clinical characteristics of the patients with or without electrophysiological neuropathy, absence of deep tendon jerks (p < 0.005) and presence of extra articular manifestations (p < 0.01) were conspicuous in the neuropathic group. There was no relation of neuropathy with the duration of RA, seropositivity, joint erosions, joint deformities, prior disease-modifying anti-rheumatic drugs or glucocorticoid intake, and 28-joint disease activity score. Neuropathy in RA was mostly subclinical and predominantly axonal. Pathologically, neuropathy secondary to amyloid infiltration was second only to vasculitic neuropathy. Absence of deep tendon jerks and presence of vasculitis were more commonly observed in patients with neuropathy.

Entities:  

Mesh:

Year:  2007        PMID: 18084807     DOI: 10.1007/s10067-007-0804-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS.

Authors:  C A PALLIS; J T SCOTT
Journal:  Br Med J       Date:  1965-05-01

2.  Neuropathy in rheumatoid disease.

Authors:  V L STEINBERG
Journal:  Br Med J       Date:  1960-05-28

3.  Steroid therapy and vascular lesions in rheumatoid arthritis.

Authors:  R L JOHNSON; C J SMYTH; G W HOLT; A LUBCHENCO; E VALENTINE
Journal:  Arthritis Rheum       Date:  1959-06

4.  Sensorimotor peripheral neuropathy in rheumatoid arthritis.

Authors:  P A McCombe; A C Klestov; A E Tannenberg; J B Chalk; M P Pender
Journal:  Clin Exp Neurol       Date:  1991

5.  Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy.

Authors:  MiedanyYasserM El; Samia Ashour; Hossam Moustafa; Ihab Ahmed
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

6.  The electroneurophysiological findings in rheumatoid arthritis patients.

Authors:  A Sivri; F Güler-Uysal
Journal:  Electromyogr Clin Neurophysiol       Date:  1999 Oct-Dec

7.  Rheumatoid neuropathy.

Authors:  D N Golding
Journal:  Br Med J       Date:  1971-04-17

8.  Myopathy and neuropathy in rheumatoid arthritis. A quantitative controlled electromyographic study.

Authors:  S I Bekkelund; T Torbergsen; G Husby; S I Mellgren
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

9.  Neuropathy in rheumatoid arthritis.

Authors:  M Y Nadkar; R Agarwal; R S Samant; S J Chhugani; S S Idgunji; S Iyer; N E Borges
Journal:  J Assoc Physicians India       Date:  2001-02

10.  [Vascular neuropathies].

Authors:  J Pouget
Journal:  Rev Prat       Date:  2000-04-01
View more
  23 in total

Review 1.  Beyond the joints: neurological involvement in rheumatoid arthritis.

Authors:  Cesar Ramos-Remus; Sergio Duran-Barragan; Jose Dionisio Castillo-Ortiz
Journal:  Clin Rheumatol       Date:  2011-09-20       Impact factor: 2.980

Review 2.  Diagnosis and therapeutic options for peripheral vasculitic neuropathy.

Authors:  Franz Blaes
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-04       Impact factor: 5.346

3.  Neurologic manifestations of systemic immunopathological diseases.

Authors:  Marc Gotkine; Adi Vaknin-Dembinsky
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.598

4.  Sonographic assessment of carpal tunnel syndrome in rheumatoid arthritis: prevalence and correlation with disease activity.

Authors:  Omer Karadag; Umut Kalyoncu; Ali Akdogan; Yesim Sucullu Karadag; Sule Apras Bilgen; Senay Ozbakır; Emilio Filippucci; Sedat Kiraz; Ihsan Ertenli; Walter Grassi; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2011-05-24       Impact factor: 2.631

5.  Peripheral nervous system manifestations in systemic autoimmune diseases.

Authors:  Inimioara Mihaela Cojocaru; Manole Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2014-09

6.  Evaluation of functional ability of rheumatoid arthritis based on HAQ score and BMD among South Indian patients.

Authors:  U Snekhalatha; M Anburajan
Journal:  Rheumatol Int       Date:  2011-04-05       Impact factor: 2.631

Review 7.  Peripheral neuropathies in rheumatic disease--a guide to diagnosis.

Authors:  Jean-Michel Vallat; Magalie Rabin; Laurent Magy
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

8.  Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors.

Authors:  Julius Birnbaum; Clifton O Bingham
Journal:  Semin Arthritis Rheum       Date:  2013-10-30       Impact factor: 5.532

Review 9.  Pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Curr Pain Headache Rep       Date:  2012-12

10.  The predictors of foot ulceration in patients with rheumatoid arthritis.

Authors:  Jill Firth; Robin Waxman; Graham Law; E Andrea Nelson; Philip Helliwell; Heidi Siddle; Simon Otter; Violet Butters; Lesley Baker; Rosemary Hryniw; Sarah Bradley; Lorraine Loughrey; Begonya Alcacer-Pitarch; Samantha Davies; Jennifer Tranter
Journal:  Clin Rheumatol       Date:  2013-12-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.